MedPath

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Not Applicable
Completed
Conditions
Hypoparathyroidism
Endocrine System Diseases
Neoplasms by Site
Neoplasms
Thyroid Diseases
Head and Neck Neoplasms
Thyroid Neoplasms
Endocrine Gland Neoplasms
Parathyroid Diseases
Registration Number
NCT05022667
Lead Sponsor
University of Michigan
Brief Summary

This study will see if the use of near infrared autofluorescence (NIRAF) detection with a 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx) is better than surgeon's detection alone. It compares risk, benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

Detailed Description

Prior to data collection, it was determined some additional outcome measures collected by the primary site would not be relevant to the trial for participating sites such as this site. Those outcomes were removed from this record.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria
  • Patients with thyroid disease who will be undergoing total thyroidectomy (includes patients who have undergone a prior neck exploration for parathyroid disease or other but have an intact thyroid gland).
  • Patients with persisting thyroid disease and will be undergoing re-operative or completion thyroidectomy.
Exclusion Criteria
  • Pregnant women
  • Patients with concurrent parathyroid and thyroid disease
  • Patients with incidental enlarged parathyroid discovered during thyroidectomy procedure.
  • Patients undergoing thyroid lobectomy or partial thyroidectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per PatientImmediate (During total thyroidectomy procedure)

Overall number of parathyroid glands identified (Experimental Group: Glands identified with naked eye + NIRAF; Control Group: Glands identified with naked eye)

Secondary Outcome Measures
NameTimeMethod
Blood Parathyroid Hormone (PTH) Levels at 5-14 Days After Surgery5-14 days after surgery

Blood parathyroid hormone (PTH) levels at 5-14 days post-op

Blood Parathyroid Hormone (PTH) Levels at 24-48 Hours After SurgeryWithin 24-48 hours after surgery

Blood parathyroid hormone (PTH) levels at 24-48 hours after surgery

Blood Calcium Levels 24-48 Hours After SurgeryWithin 24-48 hours after surgery

Blood calcium levels 24-48 hours after surgery

Duration in Minutes of SurgeryCollected immediately following surgery

Duration of surgery (minutes)

Number of Frozen Section Analysis Performed.Collected immediately following surgery

Number of frozen section analysis performed. Samples of a suspected piece of parathyroid tissue were removed and analyzed to confirm whether they were actually parathyroid tissue. Results reflect the participants who were determined to have had a frozen section conducted.

Number of Auto-transplanted Parathyroid GlandsImmediate. During total thyroidectomy procedure

Number of auto-transplanted parathyroid glands if the parathyroid gland was accidentally excised/devascularized.

Number of Nights Spent in the Hospital After Total Thyroidectomy0 - 4 nights after total thyroidectomy

Number of nights spent for postoperative recovery in the hospital after the surgical procedure.

Number of Inadvertently Resected Parathyroid GlandsImmediate (intraoperative) to 7-10 days after total thyroidectomy (as presented in the pathology report)

Number of inadvertently resected parathyroid glands when parathyroid tissue is found in the resected thyroid specimens. Results reflect the participants who had an inadvertently resected parathyroid gland.

Trial Locations

Locations (1)

The University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

The University of Michigan
🇺🇸Ann Arbor, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.